查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1866524

全球基因合成市场－2025-2030年预测

Global Gene Synthesis Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 146 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

基因合成市场预计将从 2025 年的 23.04 亿美元快速成长到 2030 年的 52.34 亿美元，复合年增长率为 17.83%。

基因合成是一种在体外逐碱基地化学合成编码遗传讯息的双链DNA序列的技术，是疫苗研发、基因治疗、分子工程和重组DNA生产的重要工具。近年来，技术的进步使得引入修饰核苷酸和新型碱基对成为可能，并有望扩展遗传密码。

基因合成市场的发展主要得益于基因组学和次世代定序研发投入的不断成长。政府资金的增加和人们对基因组学日益浓厚的兴趣也推动了市场的进一步扩张。然而，基因合成技术的高成本和复杂性构成了重大挑战。此外，熟练这些技术的专业人才短缺也可能在预测期内阻碍市场成长。

本报告检验了当前市场趋势以及需求、供应和销售的最新发展。报告详细分析了影响市场的关键驱动因素、限制因素和机会，并按地理区域详细阐述了行业趋势、政策和法规，使相关人员能够全面了解法规结构和影响市场的关键因素。

我们的竞争情报是基于广泛的二手资料研究，旨在识别关键参与企业及其收入贡献。资讯来源包括产业协会分析、分析师报告、投资者报告、新闻稿和学术期刊。

基因合成产业及其关键细分市场的市场规模采用自下而上和自上而下的方法进行计算。相关数据已透过全球基因合成价值链相关人员的第一手资讯检验。此综合市场分析整合了多种资讯来源和专有资料集，并运用资料三角测量技术进行市场区隔和预测。

透过分析性叙述、图表和图形呈现市场洞察，以帮助客户有效掌握全球基因合成市场的市场动态。重点介绍的企业包括 Evonetix、Genewiz 和 ATUM。

本报告为业内专业人士提供关于市场趋势、监管环境和竞争动态的关键洞察。报告重点阐述了基因组学主导创新带来的机会，同时也探讨了成本、复杂性和人才短缺等挑战。报告采用严谨的分析方法，结合一手和二手数据，确保提供可靠的洞察，并帮助相关人员在技术进步和应用拓展带来的快速发展中，掌握投资重点、应对复杂的监管环境和竞争压力。

本报告的主要优势：

  • 深入分析：取得以客户群、政府政策和社会经济因素、消费者偏好、垂直产业和其他细分市场为重点的深入市场洞察，涵盖主要地区和新兴地区。
  • 竞争格局：了解主要企业采取的策略倡议，并了解透过正确的策略打入市场的潜力。
  • 市场驱动因素与未来趋势：探索动态因素和关键市场趋势，以及它们将如何塑造未来的市场发展。
  • 可执行的建议：利用洞察力为策略决策提供讯息，从而在动态环境中开拓新的业务管道和收入来源。
  • 受众范围广：对新兴企业、研究机构、顾问公司、中小企业和大型企业都有益处且经济高效。

它是用来做什么的？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及其影响、新产品开发、竞争影响

分析范围

  • 历史资料（2022-2024 年）和预测资料（2025-2030 年）
  • 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按业务板块和地区（国家）分類的收入成长和预测分析
  • 公司概况（策略、产品、财务资讯、关键趋势等）

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 分析范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策和法规
  • 策略建议

第四章 技术展望

5. 全球基因合成市场依产品类型和服务类型划分

  • 介绍
  • 基因合成产物
  • 基因合成服务
  • 软体和生物资讯学工具

6. 全球基因合成市场（依技术划分）

  • 介绍
  • 固相合成
  • 基于晶片的合成
  • 基于PCR的酶促合成
  • 其他的

7. 全球基因合成市场（依基因类型划分）

  • 介绍
  • 标准基因合成
  • 极具挑战性的基因合成
  • 密码子优化基因
  • 其他的

8. 全球基因合成市场（依应用领域划分）

  • 介绍
  • 合成生物学
  • 基因工程
  • 诊断和治疗药物的研发
  • 蛋白质工程
  • 工业生物技术
  • 其他的

9. 全球基因合成市场（依最终用户划分）

  • 介绍
  • 製药和医疗公司
  • CRO（委外研发机构）
  • 学术和研究机构
  • 诊断和检测机构
  • 其他的

第十章 全球基因合成市场（依地区划分）

  • 介绍
  • 北美洲
    • 依产品类型/服务类型
    • 透过技术
    • 依基因类型
    • 透过使用
    • 最终用户
    • 按国家/地区
      • 美国
      • 加拿大
      • 墨西哥
  • 南美洲
    • 依产品类型/服务类型
    • 透过技术
    • 依基因类型
    • 透过使用
    • 最终用户
    • 按国家/地区
      • 巴西
      • 阿根廷
      • 其他的
  • 欧洲
    • 依产品类型/服务类型
    • 透过技术
    • 依基因类型
    • 透过使用
    • 最终用户
    • 按国家/地区
      • 英国
      • 德国
      • 法国
      • 义大利
      • 其他的
  • 中东和非洲
    • 依产品类型/服务类型
    • 透过技术
    • 依基因类型
    • 透过使用
    • 最终用户
    • 按国家/地区
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 其他的
  • 亚太地区
    • 依产品类型/服务类型
    • 透过技术
    • 依基因类型
    • 透过使用
    • 最终用户
    • 按国家/地区
      • 日本
      • 中国
      • 印度
      • 韩国
      • 台湾
      • 其他的

第十一章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 企业合併、协议、商业合作
  • 竞争对手仪錶板

第十二章：公司简介

  • Thermo Fisher Scientific Inc.
  • Azenta Life Sciences
  • GenScript Biotech Corporation
  • Eurofins Genomics LLC
  • ATUM
  • Synbio Technologies LLC
  • Epoch Life Science Inc.
  • GCC Biotech Pvt. Ltd.
  • Twist Bioscience Corporation
  • Integrated DNA Technologies, Inc.
  • OriGene Technologies, Inc.
  • Biomatik

第十三章 分析方法

简介目录
Product Code: KSI061611929

The Gene Synthesis Market will surge from USD 2.304 billion in 2025 to USD 5.234 billion by 2030, fueled by a 17.83% CAGR.

Gene synthesis entails the chemical, base-by-base in vitro creation of double-stranded DNA sequences encoding genes, serving as a vital tool in vaccine development, gene therapy, molecular engineering, and recombinant DNA production. Recent advancements enable the integration of modified nucleotides or novel base pairs, potentially expanding the genetic code.

The gene synthesis market is propelled by increased investments in genomics and next-generation sequencing research and development. Growing government funding and interest in genomics further drive market expansion. However, high costs and technical complexities of gene synthesis methods present significant challenges. A shortage of skilled professionals proficient in these techniques may also hinder market growth during the forecast period.

This research examines current market trends in demand, supply, and sales, alongside recent developments. It provides an in-depth analysis of key drivers, restraints, and opportunities shaping the market. The study details industry trends, policies, and regulations across geographical regions, offering stakeholders a comprehensive understanding of the regulatory framework and critical factors influencing the market.

Competitive intelligence identifies major industry players and their revenue contributions, derived from extensive secondary research. Sources include industry association studies, analyst reports, investor presentations, press releases, and journals.

Market size for the gene synthesis sector and its key segments was determined using both bottom-up and top-down approaches. Values were validated with primary inputs from stakeholders in the global gene synthesis value chain. Comprehensive market engineering integrated data from diverse sources and proprietary datasets, employing data triangulation for market breakdown and forecasting.

Market insights are presented through analytical narratives, charts, and graphics, enabling clients to efficiently grasp the global gene synthesis market dynamics. Key players profiled include Evonetix, Genewiz, and ATUM, among others.

This report equips industry experts with critical insights into market trends, regulatory landscapes, and competitive dynamics. It highlights opportunities in genomics-driven innovations while addressing challenges such as cost, complexity, and talent scarcity. The rigorous methodology, blending primary and secondary data, ensures reliable findings, enabling stakeholders to navigate investment priorities, regulatory complexities, and competitive pressures in a rapidly evolving field driven by technological advancements and expanding applications.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

By Product Type & Service Type

  • Gene Synthesis Products
  • Gene Synthesis Services
  • Software & Bioinformatics Tools

By Technology

  • Solid-Phase Synthesis
  • Chip-Based Synthesis
  • PCR-Based Enzyme Synthesis
  • Others

By Gene Type

  • Standard Gene Synthesis
  • Complex Gene Synthesis
  • Codon-Optimized Genes
  • Others

By Application

  • Synthetic Biology
  • Genetic Engineering
  • Diagnostics & Therapeutics Development
  • Protein Engineering
  • Industrial Biotechnology
  • Others

By End-User

  • Pharmaceuticals and Biopharmaceutical Companies
  • Contract Research Organisations (CROs)
  • Academic & Research Institutes
  • Diagnostics Laboratories
  • Others

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GENE SYNTHESIS MARKET BY PRODUCT TYPE & SERVICE TYPE

  • 5.1. Introduction
  • 5.2. Gene Synthesis Products
  • 5.3. Gene Synthesis Services
  • 5.4. Software & Bioinformatics Tools

6. GENE SYNTHESIS MARKET BY TECHNOLOGY

  • 6.1. Introduction
  • 6.2. Solid-Phase Synthesis
  • 6.3. Chip-Based Synthesis
  • 6.4. PCR-Based Enzyme Synthesis
  • 6.5. Others

7. GENE SYNTHESIS MARKET GENE TYPE

  • 7.1. Introduction
  • 7.2. Standard Gene Synthesis
  • 7.3. Complex Gene Synthesis
  • 7.4. Codon-Optimized Genes
  • 7.5. Others

8. GENE SYNTHESIS MARKET BY APPLICATION

  • 8.1. Introduction
  • 8.2. Synthetic Biology
  • 8.3. Genetic Engineering
  • 8.4. Diagnostics & Therapeutics Development
  • 8.5. Protein Engineering
  • 8.6. Industrial Biotechnology
  • 8.7. Others

9. GENE SYNTHESIS MARKET BY END-USER

  • 9.1. Introduction
  • 9.2. Pharmaceuticals and Biopharmaceutical Companies
  • 9.3. Contract Research Organisations (CROs)
  • 9.4. Academic & Research Institutes
  • 9.5. Diagnostics Laboratories
  • 9.6. Others

10. GENE SYNTHESIS MARKET BY GEOGRAPHY

  • 10.1. Introduction
  • 10.2. North America
    • 10.2.1. By Product Type & Service Type
    • 10.2.2. By Technology
    • 10.2.3. By Gene Type
    • 10.2.4. By Application
    • 10.2.5. By End-User
    • 10.2.6. By Country
      • 10.2.6.1. United States
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. South America
    • 10.3.1. By Product Type & Service Type
    • 10.3.2. By Technology
    • 10.3.3. By Gene Type
    • 10.3.4. By Application
    • 10.3.5. By End-User
    • 10.3.6. By Country
      • 10.3.6.1. Brazil
      • 10.3.6.2. Argentina
      • 10.3.6.3. Others
  • 10.4. Europe
    • 10.4.1. By Product Type & Service Type
    • 10.4.2. By Technology
    • 10.4.3. By Gene Type
    • 10.4.4. By Application
    • 10.4.5. By End-User
    • 10.4.6. By Country
      • 10.4.6.1. United Kingdom
      • 10.4.6.2. Germany
      • 10.4.6.3. France
      • 10.4.6.4. Italy
      • 10.4.6.5. Others
  • 10.5. Middle East & Africa
    • 10.5.1. By Product Type & Service Type
    • 10.5.2. By Technology
    • 10.5.3. By Gene Type
    • 10.5.4. By Application
    • 10.5.5. By End-User
    • 10.5.6. By Country
      • 10.5.6.1. Saudi Arabia
      • 10.5.6.2. UAE
      • 10.5.6.3. Others
  • 10.6. Asia Pacific
    • 10.6.1. By Product Type & Service Type
    • 10.6.2. By Technology
    • 10.6.3. By Gene Type
    • 10.6.4. By Application
    • 10.6.5. By End-User
    • 10.6.6. By Country
      • 10.6.6.1. Japan
      • 10.6.6.2. China
      • 10.6.6.3. India
      • 10.6.6.4. South Korea
      • 10.6.6.5. Taiwan
      • 10.6.6.6. Others

11. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 11.1. Major Players and Strategy Analysis
  • 11.2. Market Share Analysis
  • 11.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 11.4. Competitive Dashboard

12. COMPANY PROFILES

  • 12.1. Thermo Fisher Scientific Inc.
  • 12.2. Azenta Life Sciences
  • 12.3. GenScript Biotech Corporation
  • 12.4. Eurofins Genomics LLC
  • 12.5. ATUM
  • 12.6. Synbio Technologies LLC
  • 12.7. Epoch Life Science Inc.
  • 12.8. GCC Biotech Pvt. Ltd.
  • 12.9. Twist Bioscience Corporation
  • 12.10. Integrated DNA Technologies, Inc.
  • 12.11. OriGene Technologies, Inc.
  • 12.12. Biomatik

13. RESEARCH METHODOLOGY